238 related articles for article (PubMed ID: 35216968)
1. Effect of risk-reducing salpingo-oophorectomy on sex steroid hormone serum levels among postmenopausal women: an NRG Oncology/Gynecologic Oncology Group study.
Mai PL; Miller A; Black A; Falk RT; Boggess JF; Tucker K; Stuckey AR; Rodriguez GC; Wong C; Amatruda TT; Wilkinson KJ; Modesitt SC; Yamada SD; Bixel KL; Glaser GE; Rose PG; Greene MH; Sherman ME
Am J Obstet Gynecol; 2022 Jul; 227(1):61.e1-61.e18. PubMed ID: 35216968
[TBL] [Abstract][Full Text] [Related]
2. Steroid hormone levels in postmenopausal hysterectomised women with and without ovarian conservation: the continuous endocrine function of the ovaries.
Nunes E; Gallardo E; Morgado-Nunes S; Fonseca-Moutinho J
J Obstet Gynaecol; 2023 Dec; 43(1):2141618. PubMed ID: 36331514
[TBL] [Abstract][Full Text] [Related]
3. Sexual functioning more than 15 years after premenopausal risk-reducing salpingo-oophorectomy.
Terra L; Beekman MJ; Engelhardt EG; Heemskerk-Gerritsen BAM; van Beurden M; Roeters van Lennep JE; van Doorn HC; de Hullu JA; Van Dorst EBL; Mom CH; Slangen BFM; Gaarenstroom KN; van der Kolk LE; Collée JM; Wevers MR; Ausems MGEM; Van Engelen K; van de Beek I; Berger LPV; van Asperen CJ; Gomez Garcia EB; Maas AHEM; Hooning MJ; Aaronson NK; Mourits MJE; van Leeuwen FE
Am J Obstet Gynecol; 2023 Apr; 228(4):440.e1-440.e20. PubMed ID: 36403862
[TBL] [Abstract][Full Text] [Related]
4. Ovarian cancer incidence and death in average-risk women undergoing bilateral salpingo-oophorectomy at benign hysterectomy.
Cusimano MC; Ferguson SE; Moineddin R; Chiu M; Aktar S; Liu N; Baxter NN
Am J Obstet Gynecol; 2022 Feb; 226(2):220.e1-220.e26. PubMed ID: 34563499
[TBL] [Abstract][Full Text] [Related]
5. The relationship between bilateral oophorectomy and plasma hormone levels in postmenopausal women.
Kotsopoulos J; Shafrir AL; Rice M; Hankinson SE; Eliassen AH; Tworoger SS; Narod SA
Horm Cancer; 2015 Feb; 6(1):54-63. PubMed ID: 25523946
[TBL] [Abstract][Full Text] [Related]
6. Risk-reducing Bilateral Salpingo-oophorectomy: Assessing the Incidence of Occult Ovarian Cancer and Surgeon Adherence to Recommended Practices.
Newcomb LK; Toal CT; Rindos NB; Wang L; Mansuria SM
J Minim Invasive Gynecol; 2020; 27(7):1511-1515. PubMed ID: 31927044
[TBL] [Abstract][Full Text] [Related]
7. Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study.
Laughlin GA; Barrett-Connor E; Kritz-Silverstein D; von Mühlen D
J Clin Endocrinol Metab; 2000 Feb; 85(2):645-51. PubMed ID: 10690870
[TBL] [Abstract][Full Text] [Related]
8. What happens after menopause? (WHAM): A prospective controlled study of depression and anxiety up to 12 months after premenopausal risk-reducing bilateral salpingo-oophorectomy.
Hickey M; Moss KM; Brand A; Wrede CD; Domchek SM; Meiser B; Mishra GD; Joffe H
Gynecol Oncol; 2021 May; 161(2):527-534. PubMed ID: 33583580
[TBL] [Abstract][Full Text] [Related]
9. Adherence to risk-reducing salpingo-oophorectomy guidelines among gynecologic oncologists compared to general gynecologists.
Blustein P; Werner SR; Uppalapati P; Leung TM; Husk GA; Pereira EB; Whyte JS; Villella JA
Am J Obstet Gynecol; 2023 Sep; 229(3):280.e1-280.e8. PubMed ID: 37308046
[TBL] [Abstract][Full Text] [Related]
10. Uptake and timing of risk-reducing salpingo-oophorectomy among patients with BRCA1 and BRCA2 mutations.
Smith MJ; Gerber D; Olsen A; Khouri OR; Wang Y; Liu M; Smith J; Pothuri B
Am J Obstet Gynecol; 2021 Nov; 225(5):508.e1-508.e10. PubMed ID: 34171390
[TBL] [Abstract][Full Text] [Related]
11. Estimated Ovulatory Years Prior to Menopause and Postmenopausal Endogenous Hormone Levels.
Cramer DW; Vitonis AF; Huang T; Shafrir AL; Eliassen AH; Barbieri RL; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2023 Jul; 32(7):976-985. PubMed ID: 37127868
[TBL] [Abstract][Full Text] [Related]
12. Preventing Ovarian Cancer through early Excision of Tubes and late Ovarian Removal (PROTECTOR): protocol for a prospective non-randomised multi-center trial.
Gaba F; Robbani S; Singh N; McCluggage WG; Wilkinson N; Ganesan R; Bryson G; Rowlands G; Tyson C; Arora R; Saridogan E; Hanson H; Burnell M; Legood R; Evans DG; Menon U; Manchanda R;
Int J Gynecol Cancer; 2021 Feb; 31(2):286-291. PubMed ID: 32907814
[TBL] [Abstract][Full Text] [Related]
13. Peripheral and ovarian venous concentrations of steroid and gonadotropin hormones in postmenopausal women with epithelial ovarian tumors.
Heinonen PK; Koivula T; Rajaniemi H; Pystynen P
Gynecol Oncol; 1986 Sep; 25(1):1-10. PubMed ID: 3732908
[TBL] [Abstract][Full Text] [Related]
14. Short- and long-term outcomes for single-port risk-reducing salpingo-oophorectomy with and without hysterectomy for women at risk for gynecologic cancer.
Carr CE; Chambers L; Jernigan AM; Freeman L; Escobar PF; Michener CM
Int J Gynecol Cancer; 2021 Feb; 31(2):215-221. PubMed ID: 32948638
[TBL] [Abstract][Full Text] [Related]
15. Salpingo-oophorectomy or surveillance for ovarian endometrioma in asymptomatic premenopausal women: a cost-effectiveness analysis.
Orlando MS; Cadish LA; Shepherd JP; Falcone T; Chang OH; Kho RM
Am J Obstet Gynecol; 2022 Aug; 227(2):311.e1-311.e7. PubMed ID: 35490792
[TBL] [Abstract][Full Text] [Related]
16. Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Virgilio-Menopause-Health Group.
Pasquali R; Vicennati V; Bertazzo D; Casimirri F; Pascal G; Tortelli O; Labate AM
Metabolism; 1997 Jan; 46(1):5-9. PubMed ID: 9005961
[TBL] [Abstract][Full Text] [Related]
17. Association of Salpingectomy With Delayed Oophorectomy Versus Salpingo-oophorectomy With Quality of Life in BRCA1/2 Pathogenic Variant Carriers: A Nonrandomized Controlled Trial.
Steenbeek MP; Harmsen MG; Hoogerbrugge N; de Jong MA; Maas AHEM; Prins JB; Bulten J; Teerenstra S; van Bommel MHD; van Doorn HC; Mourits MJE; van Beurden M; Zweemer RP; Gaarenstroom KN; Slangen BFM; Brood-van Zanten MMA; Vos MC; Piek JMJ; van Lonkhuijzen LRCW; Apperloo MJA; Coppus SFPJ; Massuger LFAG; IntHout J; Hermens RPMG; de Hullu JA
JAMA Oncol; 2021 Aug; 7(8):1203-1212. PubMed ID: 34081085
[TBL] [Abstract][Full Text] [Related]
18. Ovarian volumes among women with endometrial carcinoma: associations with risk factors and serum hormones.
Sherman ME; Madigan MP; Lacey JV; Garcia-Closas M; Potischman N; Carreon JD; Hartge P; Brinton LA
Gynecol Oncol; 2007 Dec; 107(3):431-5. PubMed ID: 17720234
[TBL] [Abstract][Full Text] [Related]
19. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density.
Rannevik G; Jeppsson S; Johnell O; Bjerre B; Laurell-Borulf Y; Svanberg L
Maturitas; 1995 Feb; 21(2):103-13. PubMed ID: 7752947
[TBL] [Abstract][Full Text] [Related]
20. Prospective follow-up of quality of life for participants undergoing risk-reducing salpingo-oophorectomy or ovarian cancer screening in GOG-0199: An NRG Oncology/GOG study.
Mai PL; Huang HQ; Wenzel LB; Han PK; Moser RP; Rodriguez GC; Boggess J; Rutherford TJ; Cohn DE; Kauff ND; Phillips KA; Wilkinson K; Wenham RM; Hamilton C; Powell MA; Walker JL; Greene MH; Hensley ML
Gynecol Oncol; 2020 Jan; 156(1):131-139. PubMed ID: 31759774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]